Seeing Is Believing

Currently out of the existing stock ratings of Elmar Kraus, 17 are a BUY (62.96%), 10 are a HOLD (37.04%).
Analyst Elmar Kraus, currently employed at DZ BANK, carries an average stock price target met ratio of 71.67% that have a potential upside of 16.74% achieved within 234 days. Previously, Elmar Kraus worked at STIFEL.
Elmar Kraus’s has documented 54 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 04-Nov-2025.
Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 1/21/2022. The price target of $291 was fulfilled within 75 days with a profit of $56.47 (24.08%) receiving and performance score of 3.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$157
$-25.09 (-13.78%)
$118
26 days ago
(21-Nov-2025)
0/3 (0%)
$-18.3 (-10.44%)
Hold
$202
$19.91 (10.93%)
$287
1 months 11 days ago
(06-Nov-2025)
15/25 (60%)
$48.57 (31.66%)
215
Buy
$210
$27.91 (15.33%)
$213
1 months 16 days ago
(31-Oct-2025)
39/70 (55.71%)
$55.73 (36.12%)
121
Hold
$149
$-33.09 (-18.17%)
$152
2 months 7 days ago
(10-Oct-2025)
24/47 (51.06%)
$2.43 (1.66%)
266
Hold
2 months 23 days ago
(24-Sep-2025)
7/32 (21.88%)
$112.06 (70.95%)
255
Which stock is Elmar Kraus is most bullish on?
What Year was the first public recommendation made by Elmar Kraus?